Peptide Comparison
Thymosin Alpha-1 vs Thymalin
Editorial breakdown of mechanism, evidence, decision criteria, and the misconceptions worth calling out.
Data-derived verdict
Thymosin Alpha-1 and Thymalin share the thymic class and carry roughly equivalent evidence (Approved in ~30 countries / Russian Clinical + Observational). On the catalogued data layer Thymosin Alpha-1 has a slight edge: more cited sources or efficacy data on file. For most research framings either pick is defensible; Thymosin Alpha-1's evidence base is currently denser.
Evidence at a glance
FDA-approved Phase 3 Phase 2 / approved abroad Anecdotal + animal Preclinical / flagged
Side-by-side
| Thymosin Alpha-1 | Thymalin | |
|---|---|---|
| Class | Thymic peptide; immunomodulator | Thymic peptide extract; immunomodulator |
| Drug class | Immune | Immune |
| Mechanism | Activates TLR-9 and TLR-2; enhances T-cell maturation and NK cell function; restores immune balance | Restores T-cell function; immune regulation in aged patients |
| Route | SC injection | IM |
| Half-life | ~2 hrs | Variable |
| Dosage (research) | 1.6 mg SC 2x weekly (hepatitis); 0.9 mg/m² oncology trials | 10 mg IM daily for 5-10 day courses |
| Evidence tier | Approved in ~30 countries | Russian Clinical + Observational |
| Research depth | 250 indexed | 177 indexed |
| Availability | Compounding Restricted / Intl Rx | Research |
| Reported risks | Injection site reactions; rare hypersensitivity | Limited Western evidence |
Reported research data only. "Studied for" and "reported in literature" describe published research focus, not clinical recommendation. Most peptides catalogued here are not FDA-approved for human use.
Frequently asked questions
Should I pick Thymosin Alpha-1 or Thymalin?
Thymosin Alpha-1 and Thymalin share the thymic class and carry roughly equivalent evidence (Approved in ~30 countries / Russian Clinical + Observational). On the catalogued data layer Thymosin Alpha-1 has a slight edge: more cited sources or efficacy data on file. For most research framings either pick is defensible; Thymosin Alpha-1's evidence base is currently denser.
What is the difference between Thymosin Alpha-1 and Thymalin?
Thymosin Alpha-1 is classed as Thymic peptide; immunomodulator; Thymalin is classed as Thymic peptide extract; immunomodulator. Reported mechanism: Thymosin Alpha-1, Activates TLR-9 and TLR-2; enhances T-cell maturation and NK cell function; restores immune balance; Thymalin, Restores T-cell function; immune regulation in aged patients. Reported half-life: Thymosin Alpha-1, ~2 hrs; Thymalin, Variable. Routes in published studies: Thymosin Alpha-1, SC injection; Thymalin, IM.
Which has stronger evidence, Thymosin Alpha-1 or Thymalin?
Thymosin Alpha-1 has the stronger evidence base on PeptideHelper.org's five-step evidence scale, which runs from preclinical to FDA-approved. Thymosin Alpha-1 is graded Approved in ~30 countries, with 15 cited sources on its reference page and 250 indexed studies. Thymalin is graded Russian Clinical + Observational, with 2 cited sources on its reference page and 177 indexed studies.
Which is more accessible, Thymosin Alpha-1 or Thymalin?
Neither Thymosin Alpha-1 nor Thymalin is an FDA-approved drug. Catalog status: Thymosin Alpha-1, Compounding Restricted / Intl Rx; Thymalin, Research. Thymosin Alpha-1's nomination for FDA's bulk-substance lists was flagged by FDA and then withdrawn.
Are Thymosin Alpha-1 and Thymalin ever combined?
Thymosin Alpha-1 and Thymalin appear together in no stack catalogued on PeptideHelper.org, and the interaction engine raises no flag for the pair.
Open the PeptideHelper.org compare tool to add more compounds to this side-by-side and filter by evidence tier interactively.
Loading interactive view…